new_0222_0400|DSGN|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0400|DSGN|1|Design Therapeutics Inc Total Current Assets (Quarterly) (USD)|Design Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Design Therapeutics Inc Inventories (Quarterly) (USD)|Design Therapeutics Inc Net PP&E (Quarterly) (USD)|Design Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Design Therapeutics Inc Total Liabilities (Quarterly) (USD)|Design Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Design Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Design Therapeutics Inc Total Deposits (Quarterly) (USD)|Design Therapeutics Inc Book Value (Quarterly) (USD)|Design Therapeutics Inc Retained Earnings (Quarterly) (USD)|Design Therapeutics Inc Treasury Stock (Quarterly) (USD)|Design Therapeutics Inc EV to Revenues|Design Therapeutics Inc EV to Earnings|Design Therapeutics Inc EV to Free Cash Flow|Design Therapeutics Inc EV to Assets (Quarterly)|Design Therapeutics Inc PS Ratio|Design Therapeutics Inc PE Ratio|Design Therapeutics Inc Price to Book Value|Design Therapeutics Inc PEG Ratio|Design Therapeutics Inc Debt to Equity Ratio|Design Therapeutics Inc Dividend Yield|Design Therapeutics Inc Shareholder Yield (TTM)|Design Therapeutics Inc Percent of Shares Outstanding Short|Design Therapeutics Inc Total Receivables (Quarterly) (USD)|Design Therapeutics Inc Total Payables (Quarterly) (USD)|Design Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Design Therapeutics Inc Return on Invested Capital|Design Therapeutics Inc Quality Ratio Score|Design Therapeutics Inc Momentum Score|Design Therapeutics Inc Beta (1Y)|Design Therapeutics Inc Sustainable Growth Rate (TTM)|Design Therapeutics Inc Institutional Investor Ownership Percentage|Design Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Design Therapeutics Inc Total Employees (Annual)|Design Therapeutics Inc EPS Diluted (Quarterly) (USD)|Design Therapeutics Inc SG&A Expense (Quarterly) (USD)|Design Therapeutics Inc Shares Outstanding|Design Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Design Therapeutics Inc Ordinary Shares Number (Quarterly)|Design Therapeutics Inc Payout Ratio|Design Therapeutics Inc Quick Ratio (Quarterly)|Design Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Design Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Design Therapeutics Inc Effective Tax Rate (TTM)|Design Therapeutics Inc Return on Equity|Design Therapeutics Inc Net Income (TTM) (USD)|Design Therapeutics Inc Revenue (TTM) (USD)|Design Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Design Therapeutics Inc Revenue (Quarterly) (USD)|Design Therapeutics Inc Gross Profit (Quarterly) (USD)|Design Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Design Therapeutics Inc Net Income (Quarterly) (USD)|Design Therapeutics Inc Net Interest Income (Quarterly) (USD)|Design Therapeutics Inc Price (USD)|Design Therapeutics Inc Total Return Price (USD)|Design Therapeutics Inc Enterprise Value (USD)|Design Therapeutics Inc 30-Day Average Daily Volume|Design Therapeutics Inc 1 Year Price Returns (Daily)|Design Therapeutics Inc Short Interest|Design Therapeutics Inc PE Ratio (Forward)|Design Therapeutics Inc PE Ratio (Forward 1y)|Design Therapeutics Inc PS Ratio (Forward)|Design Therapeutics Inc PS Ratio (Forward 1y)|Design Therapeutics Inc Quarterly EPS Estimates (USD)|Design Therapeutics Inc Quarterly Revenue Estimates (USD)|Design Therapeutics Inc Quarterly EPS Surprise|Design Therapeutics Inc Quarterly Revenue Surprise|Design Therapeutics Inc Quarterly Actual EPS (USD)|Design Therapeutics Inc Quarterly Actual Revenue (USD)|Design Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Design Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Design Therapeutics Inc Price Target (USD)|Design Therapeutics Inc Consensus Recommendation|Design Therapeutics Inc Price Target Num Estimates|Design Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Design Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Design Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Design Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Design Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Design Therapeutics Inc Land and Improvements (Quarterly) (USD)|Design Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Design Therapeutics Inc Other Properties (Quarterly) (USD)|Design Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0400|DSGN|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0400|DSGN|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0400|DSGN|5|91|91||91||91|91|91||91|91||1.44298245614|91.5|1.44298245614|91.5|1.44298245614||1.44|||1.44298245614||15.3|91|91|91||||||30.6|91.3333333333|192|91.3333333333|91.3333333333|28.5||91|||91.3333333333|91.3333333333|||91|||91.6666666667||91.3333333333|91.3333333333||1.44298245614|1.44298245614|1.44298245614|1.44221105528||15.3|||||91.4285714286|91.4285714286|91.5||91.5|91.5|27.5|30.5555555556|33.6666666667|15.15|33.6666666667|30.4444444444|34.25|91.3333333333|91.3333333333||||91|92||
new_0222_0400|DSGN|6|3|3||3||3|3|3||3|3||228|2|228|2|228||225|||228||20|3|3|3||||||10|6|1|6|6|8||3|||6|6|||3|||3||6|6||228|228|228|199||20|||||7|7|2||2|2|10|9|9|20|9|9|8|6|6||||3|1||
new_0222_0400|DSGN|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0400|DSGN|202003||||||||||||||||||||||||||||||||||27.193||-0.0244|0.388||||||-0.0244|||||||0.142||-0.663|-0.663|||||||||||||||||||||||||0.377||||||||
new_0222_0400|DSGN|202006||||||||||||||||||||||||||||||||||27.193||-0.053|0.433||||||-0.053|||||||0.031||-1.442|-1.442|||||||||||||||||||||||||1.061||||||||
new_0222_0400|DSGN|202009||||||||||||||||||||||||||||||||||27.193||-0.0853|0.489||||||-0.0853|||||||0.02||-2.32|-2.32|||||||||||||||||||||||||1.914|0.001|||||||
new_0222_0400|DSGN|202012|36.233|36.091||0.071||47.831|2.33|45.501||-11.315|-11.923||||||||||||||0.01|1.399|0.001|||||||53.8173||-0.0716|1.186|||53.8173||15.494|-0.0716||||-8.28|0.226||0.033||-3.855|-3.855|||||||||||||||||||||||||2.708|0.004||||0.076|||
new_0222_0400|DSGN|202103|411.754|411.339||0.1||3.848|3.706|0.142||408.006|-17.437||5462.1006|-149.0863|-127.1695|33.8053|4161.9738||4.0337|||||0.4837|0.027|2.033|0.006||||||69.8131|17.6302|20|-0.31|1.805|55.0426||55.0425|||-0.31|-254.271|||-13.131|||||-5.514|-5.514||29.9|29.9|1234.4347|105326.0667||266268|||||-0.09||-244.4444||-0.31||||35.3333|2|3|-0.49|-0.91|3.875|0.004||||0.109||26.23|26.2
new_0222_0400|DSGN|202106|404.875|402.836||0.271||3.545|3.405|0.14||401.601|-25.073||3068.1212|-83.7434|-40.8336|18.9888|3382.2228||2.7297|||||3.0342|0.076|1.585|0.006||||||72.0148|55.0814||-0.14|2.66|55.1147||55.1147|||-0.14||||-19.325|||||-7.636|-7.636||19.89|19.89|693.3954|208154.6||1672311|||||-0.22||36.3636||-0.14||||34.6667|2|3|-0.73|-0.93|5.027|0.012||||0.281|0.011|15.48|15.72
new_0222_0400|DSGN|202109|395.29|393.718||5.063||8.789|5.505|3.284||391.564|-36.391||1847.471|-50.4261|-17.2589|11.4341|2952.3638||2.0718|||||2.9216|0.047|2.216|0.006||||||73.322|55.155|33|-0.21|2.798|55.2244||55.2244|||-0.21||||-28.323|||||-11.318|-11.318||14.69|14.69|417.5284|72569.3667||1613433|||||-0.13||-61.5385||-0.21||||34.6667|2|3|-0.72|-0.85|8.539|0.031||||4.801|0.077|15.68|16.74
new_0222_0400|DSGN|202112|||||||||||||3531.0448||-32.9868||4302.9346||3.0435|||||3.9148|||||||||76.5179||||||||||||||||||||||21.41|21.41|798.0161|246596.3||2179100|||||-0.2267||||||||39|1.5|2|-0.8|-1.3833||||||||12.64|13.81
new_0222_0400|DSGN|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.2133|||||||||||||||||||||
new_0222_0400|DSGN|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.24|||||||||||||||||||||
new_0222_0400|DSGN|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.2767|||||||||||||||||||||
new_0222_0400|DSGN|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.32|||||||||||||||||||||